RE:RE: SONA - Signs w/ GE Health Care ~ 🅰️ “Game Changer"
Sona Covid-19 lateral flow test will utilize GE Healthcare Life Sciences' FFHP Membrane, which is specifically designed to allow for multiple optimization techniques (potentially allowing the test to become market ready sooner) and fast flow performance (potentially allowing for faster individual test results). Darren Rowles, CEO of Sona Nanotech, said, "It is exciting to work with a best-in-class partner like GE Healthcare Life Sciences, drawing on their expertise and to use the new FFHP Membrane. With their help, we will be able to accelerate our work and hopefully bring this critical test to the market quicker." Lateral Flow testing usually gets approved by the FDA within weeks to a month maximum while other sorts of testing can take years to be approved. GE's Lifesciences will be spreading the work all over different departments.